Dietary changes to help adults with Type 1 diabetes and overweight see if moderate carbs, time-restricted eating, or regular calories work
Official title: Dietary Approaches for the Management of Overweight and Obesity in Type 1 Diabetes: The D1ANA Study
Run by Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud · NCT07667504 · Data updated 2026-11-12
We’re testing three weight-loss approaches in adults with type 1 diabetes who are overweight or obese to see which helps reduce weight safely.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 75 (estimated) |
| Sponsor | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud Academic / other |
| Locations | 1 site (Málaga, Málaga) |
| Status | Recruiting |
| Started | July 2, 2026 |
| Main results expected | July 2028 |
| Study ends | July 2028 |
| Registry record updated | July 15, 2026 |
| Trial ID | NCT07667504 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with Type 1 diabetes, overweight or obese (BMI 25–45 kg/m2), on intensive insulin therapy, CGM user, and stable treatment plan.
✕Probably not a fit
Patients who do not respond to dietary interventions or who experience adverse glycemic events or safety concerns may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study compares three weight-management approaches in adults with T1D and overweight/obesity: moderate carbohydrate restriction, early time-restricted eating, and standard calorie restriction. Participants will have T1D managed with intensive insulin therapy, use CGM, and meet HbA1c and BMI criteria. The trial aims to determine which approach yields meaningful weight loss while maintaining glycemic control and safety. Outcomes likely include changes in weight, metabolic markers, and insulin requirements. The study is conducted at a single site in Málaga, Spain, led by a regional health research foundation.
Why it matters
Potential benefit: If successful, the trial could identify practical dietary options to achieve weight loss and improve health in adults with T1D and overweight/obesity.
How similar studies have gone: Previous work in Type 2 diabetes and obesity supports weight-loss strategies, but evidence in T1D is limited and this study explores novel approaches in this population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * T1D treated with intensive insulin therapy (multiple daily insulin injections or continuous subcutaneous insulin infusion systems) * HbA1c 6.5-9% * BMI ≥ 25 and ≤ 45 kg/m2 * Active prescription and use of CGM * Active prescription for glucagon Exclusion Criteria: * Pregnancy, pregnancy planning, or breastfeeding * Forms of diabetes other than T1D, or T1D duration \< 1 year * Previous cardiovascular events (acute myocardial infarction or stroke), heart failure, unstable coronary artery disease, chronic kidney disease with estimated glomerular filtration rate ≤ 30 mL/min/m², cirrhosis, or presence of active cancer * Unstable diabetes, episodes of glycemic decompensation (diabetic ketoacidosis) or severe hypoglycemia (level 3) within the past year. * Planned change in treatment during the study (switching from multiple daily insulin injections to continuous insulin infusion, or vice versa) * Use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, GLP-1/GIP agonists, or other medications that may influence weight loss * Having experienced a change in body weight greater than 5% within the 3 months before screening * Following any form of diet prior to inclusion, carbohydrate restriction, or intermittent fasting * History of eating disorders or alcohol abuse * Inability to follow the dietary recommendations * Presence of other conditions that, in the investigator's judgment, may compromise participation in the study.
Where it's running
-
Virgen de la Victoria University Hospital
Málaga, Málaga, Spain Recruiting
Study contacts
- Principal investigator: José Ignacio Martínez-Montoro, MD, PhD — Virgen de la Victoria University Hospital, Málaga, Spain
- Study coordinator: José Ignacio Martínez-Montoro, MD, PhD
- Email: martinezmontoro@ibima.eu
- Phone: +34 951032647
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How incretin treatments affect muscle mass and function in people with overweight or obesity
This study will see how drugs like semaglutide and tirzepatide influence fat-free mass, muscle strength, and physical function in adults with overweight or obesity.
-
Dose find for remimazolam plus alfentanil for gastroscopy in obese adults
This trial tests what dose of remimazolam besylate with alfentanil best sedates obese adults during gastroscopy.
-
Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults
This study compares how much weight adults lose over two years when starting GLP-1 medicines versus adults who had sleeve gastrectomy at the same center.
-
Gut barrier and inflammation after fast-food overfeeding in adults
This study tests whether 14 days of fast-food overfeeding can alter gut barrier function and trigger inflammation in adults who are generally healthy.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
GLP-1 weight‑loss medicine: finding who will benefit most
This study tests whether a GLP-1 drug called semaglutide helps with weight loss by changing eating behavior, to see which people it helps the most.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.